Orris

Therapeutics 2 : synopsis 1. Basic principles of cancer chemotherapeutic agents 2. General introduction of cancer chemotherapeutic agents ( classification, basic moa , indications and common adrs ) 3. Chemo induced nausea and vomiting 4. Management of breast cancer and leukaemia

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
This is a comprehensive synopsis covering all four topics. Here is a quick orientation:
What's covered:
  1. Basic Principles — Goals of therapy (cure/control/palliation), types of chemotherapy (adjuvant/neoadjuvant/maintenance), combination regimen rationale, cell cycle specificity, drug resistance mechanisms.
  2. Drug Classification & MOA — All major classes: alkylating agents, antimetabolites, antibiotics, vinca alkaloids, taxanes, topoisomerase inhibitors, hormonal agents, and targeted biologics — each with MOA, key indications, and signature ADRs. A system-by-system ADR table is included.
  3. CINV — Types (acute/delayed/anticipatory), the CTZ–vomiting centre pathway, emetogenic potential of drugs, and the full antiemetic protocol by emetogenic risk level.
  4. Breast Cancer — Molecular subtypes (Luminal A/B, HER2, TNBC), staging, surgical options, and the complete systemic therapy algorithm (endocrine, anti-HER2, immunotherapy, PARP inhibitors, CDK4/6 inhibitors). Leukaemia covers ALL (induction protocol, CNS prophylaxis, outcomes), AML ("7+3" regimen, targeted additions), APL (ATRA + arsenic trioxide, differentiation syndrome), CML (BCR-ABL/TKIs), and CLL.

Indetail

Checking Date & Time
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.